Cytek Biosciences Says Its 1-laser And 2-laser 6-color TBNK Reagent Cocktails Have Received China NMPA Approval For Clinical Diagnostic Use
Portfolio Pulse from Benzinga Newsdesk
Cytek Biosciences announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received approval from China's National Medical Products Administration (NMPA) for clinical diagnostic use.
May 28, 2024 | 9:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cytek Biosciences' 1-laser and 2-laser 6-color TBNK reagent cocktails have received approval from China's NMPA for clinical diagnostic use, potentially expanding their market reach in China.
The approval from China's NMPA allows Cytek Biosciences to market its reagent cocktails for clinical diagnostic use in China, potentially increasing sales and market presence in a significant market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100